Test Code Parathryroid Hormone (PTH), Intact Parathyroid Hormone (PTH), Intact
Additional Codes
Cerner |
NextGen |
Parathryroid Hormone (PTH), Intact |
PTH Intact |
Alternate Name(s)
iPTH
Intact PTH
Parathormone
Parathyrin
Useful For
Parathyroid hormone (PTH) is secreted by the parathyroid gland; after being secreted into the bloodstream, it undergoes extensive proteolysis to generate various fragments. In contrast to its degradation products, the concentration of Intact PTH is relatively independent of glomerular filtration rate and reflects the biologically active portion of the hormone.
The primary role of PTH is to maintain calcium homeostasis via its interaction with calcitonin. PTH measurement is an important aid in the diagnosis of disorders of calcium metabolism. PTH synthesis and secretion are triggered rapidly by low concentrations of ionized calcium. The biological activities of PTH are to increase absorption of dietary calcium, decrease renal clearance and mobilize skeletal calcium stores. Abnormally high ionized calcium concentrations suppress secretion of PTH. In conjunction with serum calcium levels, the PTH assay may be used as an aid in the differential diagnosis of hypercalcemia, hypocalcemia and parathyroid disorders. PTH determination is important in monitoring dialysis patients to manage renal osteodystrophy.
Intraoperative PTH testing is used during surgery for hyperparathyroidism, especially in minimally invasive or directed procedures, as well as for patients undergoing reoperation. For patients undergoing parathyroidectomy it is recommended that preoperative and pre-excision samples are taken. Samples should also be drawn at 5 and 10 minutes post resection and a >50% reduction in PTH levels from the highest baseline may be used as criteria for surgical success.
Methodology
Immunometric Immunoassay
Patient Preparation
None
Collection Instructions
- Standard phlebotomy practices.
- Plasma should be thoroughly separated from cellular material within 45 minutes of collection.
- Specimen types should not be used interchangeable during the serial monitoring of an individual patient as measured concentrations may vary slightly between sample types.
Specimen Requirements
Container |
|
||||||||||||
Stability |
|
||||||||||||
Rejection Criteria |
|
Result Reporting and Reference Values
Reported in pg/mL
Intraoperative sample drawn 5-10 minutes post-excision should decrease by at least 50% from the baseline sample.
Age |
Low |
High |
Birth -18 Years |
Not Defined |
|
18-150 Years |
14.2 |
75.2 |
Reflex Testing
None
Limitations
- Ortho reports a bias with the following:
- Patients taking Cefoxitin Sodium could have reported PTH concentrations that are negatively biased at levels indicated in the Known Interferences section.
- Rheumatoid factor at concentrations of 450 IU/mL and above have been shown to falsely elevate PTH test results.
- Total protein at concentrations of 11.6 g/dL and above have been shown to falsely decrease PTH test results.
- Ortho reports no significant effect with the following:
- Bilirubin up to 40 mg/dL
- Rheumatoid factor concentrations less than 225 IU/mL have demonstrated no observed interference.
- Total protein at concentrations less than 9.4 g/dL have demonstrated no observed interference.